148 related articles for article (PubMed ID: 12433435)
1. Preparation and dissolution characteristics of griseofulvin solid dispersions with saccharides.
Saito M; Ugajin T; Nozawa Y; Sadzuka Y; Miyagishima A; Sonobe T
Int J Pharm; 2002 Dec; 249(1-2):71-9. PubMed ID: 12433435
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the interactions of enteric and hydrophilic polymers to enhance dissolution of griseofulvin following hot melt extrusion processing.
Bennett RC; Keen JM; Bi YV; Porter S; Dürig T; McGinity JW
J Pharm Pharmacol; 2015 Jul; 67(7):918-38. PubMed ID: 25645386
[TBL] [Abstract][Full Text] [Related]
3. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F
Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988
[TBL] [Abstract][Full Text] [Related]
4. Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.
Al-Obaidi H; Lawrence MJ; Buckton G
J Pharm Pharmacol; 2016 Nov; 68(11):1373-1383. PubMed ID: 27696396
[TBL] [Abstract][Full Text] [Related]
5. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
Zecevic DE; Meier R; Daniels R; Wagner KG
Eur J Pharm Biopharm; 2014 Jul; 87(2):264-70. PubMed ID: 24768770
[TBL] [Abstract][Full Text] [Related]
6. Effect of Particle Size and Polymer Loading on Dissolution Behavior of Amorphous Griseofulvin Powder.
Zheng K; Lin Z; Capece M; Kunnath K; Chen L; Davé RN
J Pharm Sci; 2019 Jan; 108(1):234-242. PubMed ID: 30472263
[TBL] [Abstract][Full Text] [Related]
7. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of high dispersion stable nanocrystal formulation of poorly water-soluble compounds by using povacoat.
Yuminoki K; Seko F; Horii S; Takeuchi H; Teramoto K; Nakada Y; Hashimoto N
J Pharm Sci; 2014 Nov; 103(11):3772-3781. PubMed ID: 25209659
[TBL] [Abstract][Full Text] [Related]
9. Characterization and stability of ternary solid dispersions with PVP and PHPMA.
Al-Obaidi H; Ke P; Brocchini S; Buckton G
Int J Pharm; 2011 Oct; 419(1-2):20-7. PubMed ID: 21801822
[TBL] [Abstract][Full Text] [Related]
10. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
[TBL] [Abstract][Full Text] [Related]
11. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
Thenmozhi K; Yoo YJ
Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
[TBL] [Abstract][Full Text] [Related]
12. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation.
Roine J; Kaasalainen M; Peurla M; Correia A; Araújo F; Santos HA; Murtomaa M; Salonen J
Mol Pharm; 2015 Jul; 12(7):2254-64. PubMed ID: 26035734
[TBL] [Abstract][Full Text] [Related]
13. Detection of pharmaceutical drug crystallites in solid dispersions by transmission electron microscopy.
Ricarte RG; Lodge TP; Hillmyer MA
Mol Pharm; 2015 Mar; 12(3):983-90. PubMed ID: 25699402
[TBL] [Abstract][Full Text] [Related]
14. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
15. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
16. The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.
Al-Hamidi H; Obeidat WM; Nokhodchi A
Pharm Dev Technol; 2015 Jan; 20(1):74-83. PubMed ID: 24392858
[TBL] [Abstract][Full Text] [Related]
17. Griseofulvin micronization and dissolution rate improvement by supercritical assisted atomization.
Reverchon E; Della Porta G; Spada A; Antonacci A
J Pharm Pharmacol; 2004 Nov; 56(11):1379-87. PubMed ID: 15525444
[TBL] [Abstract][Full Text] [Related]
18. Poly(2-Ethyl-2-Oxazoline) as an Alternative to Poly(Vinylpyrrolidone) in Solid Dispersions for Solubility and Dissolution Rate Enhancement of Drugs.
Fael H; Ràfols C; Demirel AL
J Pharm Sci; 2018 Sep; 107(9):2428-2438. PubMed ID: 29859957
[TBL] [Abstract][Full Text] [Related]
19. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
20. Freeze-dried amorphous dispersions for solubility enhancement of thermosensitive API having low molecular lipophilicity.
Kulthe VV; Chaudhari PD; Aboul-Enein HY
Drug Res (Stuttg); 2014 Sep; 64(9):493-8. PubMed ID: 24443307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]